The American Heart Association’s new leader is prioritizing artificial intelligence to tackle long-standing gaps in the diagnosis and treatment of heart disease in women. The initiative aims to counter data and clinical biases that have left women underdiagnosed and undertreated, by funding research, validating sex-specific algorithms, and partnering with health systems to deploy tools that can improve detection and outcomes. The push comes as AI adoption accelerates across U.S. healthcare and regulators scrutinize algorithmic bias and privacy. Heart disease remains the leading cause of death among women, underscoring the need for more representative data, careful oversight, and measured deployment of AI at the point of care.
Related articles:
– Sex-specific troponin I thresholds in the diagnosis of myocardial infarction: prospective cohort study
– Heart Disease in Women: Facts
– A deep learning algorithm for cardiovascular risk prediction from medical data
